At the age of 30, the responsibility lies on the shoulders.
Release time:
2022-04-06
■ Pharmaceutical Company Fan Tufa
Newspaper Running Like Life, Years of Weathering for 30 Years, Baiwei Newspaper Running Only Known. Since its inception, "Jianfeng newspaper" has experienced the hard work and unremitting persistence of several newspaper organizers, and experienced the boring loneliness. They are rigorous, meticulous, serious and responsible in collecting, editing, writing, changing, arranging, school and so on. They are not only journalists, editors, but also manuscript reporters and typesetting workers. They have made extremely hard efforts, with a strong sense of responsibility and hard-working perseverance, for all employees dedicated a period of high-quality spiritual food.
Life is only beautiful when you come out, not brilliant when you wait out. The same is true for running newspapers. With the spirit of seeking truth and innovation and climbing the peak forever, the peak newspaper closely follows the central task of the enterprise, grasps the work focus, strengthens the publicity and agitation effect, plays a guiding role, and always focuses on the central work of the group company. In every important development period of the company, the enterprise dynamics, production and operation, etc. are used by means of news, communication, pictures, perception, etc., to show what the company's current wants, as well as the employees' thoughts and thoughts are transmitted to all cadres and employees, so that everyone has a direction and motivation to do it, so that everyone can see the company's shining point and future, and at the same time, the company can understand the hopes and needs of employees and stimulate their passion for work.
As we all know, most of the news in newspapers comes from the grassroots and cannot be separated from the support of grassroots correspondents. The peak newspaper pays attention to improving the personal quality of grass-roots correspondents. It holds correspondent training every year to improve the interview and writing ability of grass-roots correspondents. It not only increases the writing level and writing pleasure of correspondents, but also allows correspondents to taste the small sense of achievement of changing words into type, increases the number of manuscripts and enriches the quality of newspapers. As long as the company has important activities, you can see the editors and editors, track the hot activities in time, report the dynamics of the company's key operations, and the results of the company's business development, so as to enhance the role of public opinion guidance and publicity, and ensure the smooth progress of the company's development.
The development of enterprises cannot be separated from the promotion of cultural communication. 30 years have been like songs, and he has served as editor-in-chief to reporter of "Peak Newspaper". With full working spirit and pioneering and innovative newspaper running style, he has closely focused on the development and growth of the group company, collected and written the stories of peak people, recorded the development history of peak enterprises, spread the corporate culture and carried forward the corporate spirit. It is precisely the efforts that peak newspapermen have dared to take responsibility one after another, it was only the achievement of today's "Peak News" that was affirmed by all the cadres and employees of the group company, and won many proud honors in the newspaper industry.
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page